Albany Molecular Research Inc. (NASDAQ:AMRI) reported fourth quarter results for the quarter ended December 31. Total sales for the quarter rose 19% year-over-year to $56.4 million, narrowly beating consensus estimates of $54.3 million. Net income for the quarter was $3.1 million, or $0.10, excluding items, beating consensus estimates of $0.05 per share. Fiscal year 2009 total sales rose 19% year-over-year to $229.3 million, beating consensus estimates of $227.2 million. Net income for the fiscal year was $20.5 million, or $0.65 per share, excluding items, beating consensus estimates of $0.57 per share. The company expects first quarter earnings to be in the range of $0.01 - $0.02 per share, and fiscal year 2009 earnings to be in the range of $0.40 - $0.46 per share.

Contact Chip Brian

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at www.TradeTheTrend.com/signup.html